- New Partnership builds on existing relationship
- BETADINE® branding to appear on medical team apparel and kit reinforcing Official Healthcare Product Partner status
- Enhanced digital brand presence to reach global consumer audience
MANCHESTER, 21 August 2017: Mundipharma and English Premier League giants Manchester City have agreed to a new global partnership following an inaugural first season that saw Mundipharma and BETADINE® perform successfully as a regional partner of Manchester City.
Under the terms of the global partnership, the Manchester City Medical Team’s uniform and kit will feature BETADINE® logos and they’ll be equipped with BETADINE® treatments for the players. The brand will also benefit from enhanced exposure on digital display formats at home games.
Mundipharma will continue to collaborate with Manchester City to provide aspiring footballers with opportunities to develop their skills as part of co-branded Youth Development Programmes, as well as offering fans the chance to see their heroes in action through consumer-based promotions.
Commenting on the new global partnership, Mundipharma CEO, Raman Singh, who also oversees the global consumer healthcare business of all its network of independent associated companies across the world, including Europe and North America, said: “This partnership has proven to be a great fit for our brands. Manchester City is one of the world’s best-performing football teams, while we have positioned BETADINE® as a healthcare portfolio that builds personal resilience and supports well-being.”
Mr Singh added, “Football is a powerful and emotive way to engage with people and communicate messages about personal healthcare and well-being in a way that is relevant and taps into the emotional fan experience. Manchester City’s success and continued ambition provides a global platform and extraordinary reach. Football is the language the world speaks.”
Tom Glick, Chief Commercial Officer of City Football Group, added: “We are extremely pleased to have extended our partnership with Mundipharma and BETADINE®. They have been a great partner from the outset. We have been continually impressed by the creative approach they have brought to everything we have done so far. We are delighted that we now have an opportunity to work together on a global scale.”
Earlier this year, Mundipharma announced a partnership with J1 League club, Yokohama F. Marinos, which is also part of City Football Group.
Mundipharma’s independent associated companies are privately owned entities covering pharmaceutical markets in Asia-Pacific, Latin America, Middle East and Africa. The headquarters for these territories is in Singapore. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.
For more information please visit: www.mundipharma.com.sg
The BETADINE® range of medicines containing Povidone-Iodine is trusted by hospitals around the world for over 60 years to prevent and treat infections. It is also a trusted brand among consumers at home to treat small wounds and grazes, sore throats, feminine infections and to stop minor problems from escalating into big issues. In-vitro studies show that BETADINE® medicines containing Povidone-Iodine kill a broad range of bacteria, viruses and fungi including antibiotic-resistant strains that cause infections. BETADINE® has four main categories of products in Wound Care, Feminine Care, Throat / Oral Care and Infectious Diseases to meet the varying needs of our customers.
For more information please visit: www.betadine.com.sg
®: BETADINE is a registered trademark of Mundipharma
Registered indications differ country to country hence please check with a local Mundipharma office for more information on the local approved prescribing information.
About Manchester City
Manchester City is an English Premier League club initially founded in 1880 as St Mark’s West Gorton. It officially became Manchester City FC in 1894 and has since then gone onto win the European Cup Winners’ Cup, four League Championship titles, including two Premier League titles (2012, 2014), and five FA Cups. Manchester City is one of five teams comprising the City Football Group and counts New York City FC and Melbourne City FC among its sister clubs.
Under manager Pep Guardiola, one of the most highly decorated managers in world football, the Club plays its domestic and UEFA Champions League home fixtures at the Etihad Stadium, a spectacular 55,000 seat arena that City have called home since 2003. Today, the Stadium sits on the wider Etihad Campus, which also encompasses the City Football Academy, a state-of-the-art performance training and youth development facility located in the heart of East Manchester. Featuring a 7,000 capacity Academy Stadium, the City Football Academy is also where Manchester City Women’s Football Club and the Elite Development Squad train on a daily basis and play their competitive home games.
For more information, please visit www.mancity.com
For further information please contact:
Chief Communications Officer & Head, Digital Strategy –
Asia Pacific, Latin America the Middle East & Africa
+65-6303-9732 | email@example.com